Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids
- PMID: 19764786
- DOI: 10.1021/jm901036q
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids
Abstract
New experimental methodologies were applied to measure the unbound brain-to-plasma concentration ratio (K(p,uu,brain)) and the unbound CSF-to-plasma concentration ratio (K(p,uu,CSF)) in rats for 43 structurally diverse drugs. The relationship between chemical structure and K(p,uu,brain) was dominated by hydrogen bonding. Contrary to popular understanding based on the total brain-to-plasma concentration ratio (logBB), lipophilicity was not a determinant of unbound brain exposure. Although changing the number of hydrogen bond acceptors is a useful design strategy for optimizing K(p,uu,brain), future improvement of in silico prediction models is dependent on the accommodation of active drug transport. The structure-brain exposure relationships found in the rat also hold for humans, since the rank order of the drugs was similar for human and rat K(p,uu,CSF). This cross-species comparison was supported by K(p,uu,CSF) being within 3-fold of K(p,uu,brain) in the rat for 33 of 39 drugs. It was, however, also observed that K(p,uu,CSF) overpredicts K(p,uu,brain) for highly effluxed drugs, indicating lower efflux capacity of the blood-cerebrospinal fluid barrier compared to the blood-brain barrier.
Similar articles
-
Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(-/-) rats.Drug Metab Pharmacokinet. 2016 Feb;31(1):57-66. doi: 10.1016/j.dmpk.2015.10.003. Epub 2015 Nov 5. Drug Metab Pharmacokinet. 2016. PMID: 26830080
-
Quantitative investigation of the brain-to-cerebrospinal fluid unbound drug concentration ratio under steady-state conditions in rats using a pharmacokinetic model and scaling factors for active efflux transporters.Drug Metab Dispos. 2014 Jun;42(6):983-9. doi: 10.1124/dmd.113.056606. Epub 2014 Mar 18. Drug Metab Dispos. 2014. PMID: 24644297
-
Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu).Drug Metab Dispos. 2006 Feb;34(2):318-23. doi: 10.1124/dmd.105.007211. Epub 2005 Nov 22. Drug Metab Dispos. 2006. PMID: 16303872
-
Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.Adv Drug Deliv Rev. 2004 Oct 14;56(12):1825-57. doi: 10.1016/j.addr.2004.07.011. Adv Drug Deliv Rev. 2004. PMID: 15381336 Review.
-
Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations?Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):215-20. doi: 10.1111/j.1742-7843.2009.00517.x. Epub 2009 Dec 30. Basic Clin Pharmacol Toxicol. 2010. PMID: 20050843 Review.
Cited by
-
Accurate prediction of Kp,uu,brain based on experimental measurement of Kp,brain and computed physicochemical properties of candidate compounds in CNS drug discovery.Heliyon. 2024 Jan 9;10(2):e24304. doi: 10.1016/j.heliyon.2024.e24304. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38298681 Free PMC article.
-
The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery.Pharmaceutics. 2023 Nov 12;15(11):2619. doi: 10.3390/pharmaceutics15112619. Pharmaceutics. 2023. PMID: 38004597 Free PMC article. Review.
-
Uptake Transporters at the Blood-Brain Barrier and Their Role in Brain Drug Disposition.Pharmaceutics. 2023 Oct 16;15(10):2473. doi: 10.3390/pharmaceutics15102473. Pharmaceutics. 2023. PMID: 37896233 Free PMC article. Review.
-
Developmental changes in the extent of drug binding to rat plasma proteins.Sci Rep. 2023 Jan 23;13(1):1266. doi: 10.1038/s41598-023-28434-1. Sci Rep. 2023. PMID: 36690711 Free PMC article.
-
Structural Alterations of the "Address" Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG Toxicity.J Med Chem. 2023 Jan 12;66(1):577-595. doi: 10.1021/acs.jmedchem.2c01499. Epub 2022 Dec 20. J Med Chem. 2023. PMID: 36538027 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
